Corpus Intelligence IC Memo — SALEM TOWNSHIP HOSPITAL 2026-04-26 15:12 UTC
IC Memo — SALEM TOWNSHIP HOSPITAL
Investment Committee Memorandum | IL | 25 beds | Grade C | EBITDA uplift $3.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SALEM TOWNSHIP HOSPITAL

CCN 141345 | MARION, IL | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SALEM TOWNSHIP HOSPITAL is a 25-bed rural/critical access in MARION, IL with $48.3M in net patient revenue and a 20.5% operating margin. The hospital serves a payer mix of 66.9% Medicare, 0.1% Medicaid, and 33.1% commercial.

Thesis: Turnaround. Our ML models identify $3.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 20.5% to 27.8% (+736bps).

Net Revenue HCRIS$48.3M
Current EBITDA COMPUTED$9.9M
Operating Margin COMPUTED20.5%
Occupancy HCRIS26.8%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS30.4%
Distress Probability ML52.9%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
74
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 20.5% places it above the state median. Among 74 size-comparable peers (12-50 beds), the median margin is -2.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 74 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SALEM TOWNSHIP HOSPITAL (Target)IL25$48.3M20.5%
GIBSON AREA HOSPITAL AND HEALTIL25$125.0M-6.7%
GRAHAM HOSPITAL ASSOCIATIONIL43$105.0M-4.7%
PARIS COMMUNITY HOSPITALIL25$100.7M-4.2%
OSF SAINT ANTHONYS HEALTH CENTIL49$91.4M-9.8%
ST. MARGARETS HEALTH - SPRING IL44$88.1M-12.7%
SAINT JOSEPH MEMORIAL HOSPITALIL25$86.0M33.9%
MCDONOUGH DISTRICT HOSPITALIL45$79.6M-4.2%
WABASH GENERAL HOSPITALIL25$71.8M4.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$967K+200bp12mo
Denial Rate Reduction12.0%6.5%$957K+198bp12mo
A/R Days Reduction5200.0%3800.0%$588K+122bp9mo
Clean Claim Rate88.0%96.0%$31K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$967K
Denial Rate Reduction
$957K
A/R Days Reduction
$588K
Clean Claim Rate
$31K
Total EBITDA Uplift$3.6M
Current EBITDA$9.9M
+ RCM Uplift+$3.6M
Pro Forma EBITDA$13.4M
Current Margin20.5%
Pro Forma Margin27.8%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$15.2M$100.8M6.63x46.0%
Base (11x exit)10.0x11.0x$15.2M$115.8M7.61x50.1%
Bull Case9.0x11.0x$13.7M$132.5M9.68x57.5%
Bull (12x exit)9.0x12.0x$13.7M$148.6M10.85x61.1%
Bear Case11.0x10.0x$16.7M$78.1M4.67x36.1%
Bear (11x exit)11.0x11.0x$16.7M$91.3M5.46x40.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 66.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 26.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 52.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 74 hospitals with 12-50 beds
  • Same-state prioritization (n=75)
  • Comp margins: P25=-7.5% / P50=-2.2% / P75=4.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.